STOCKHOLM, November 6, 2020 - Elekta (EKTA-B.ST) announced today that it has received CE mark for its
A cancer treatment system designed to meet healthcare centers' need for a productive, precise and versatile radiotherapy treatment system,
More than a linac
The most productive linac Elekta has ever designed,
· Productivity: the new FastTrack in-room experience reduces patient setup time by as much as 50 percent**. Combined with further workflow enhancements, treatment slots can be reduced by up to 25 percent, enabling clinicians to deliver high-quality cancer care to more patients.
· Precision: a best-in-class multi-leaf collimator provides one-millimeter resolution beam-shaping across the full 40 cm X 40 cm field size, which provides "shrink-wrapped" sub-millimeter conformality around the tumor target.
· Versatility: the option of multiple energies, treatment techniques and imaging modalities, providing the versatility needed to treat the most common indications, including breast, lung, pelvic and head-and-neck cancers.
To learn more about
*
**Data maintained internally
# # #
For further information, please contact:
Tel: +46 70 865 8012, e-mail: Mattias.Thorsson@elekta.com
Time zone: CET: Central European Time
Tel: +1 770-670-2524, e-mail: raven.canzeri@elekta.com
Time zone: ET: Eastern Time
About Elekta
For almost five decades, Elekta has been a leader in precision radiation medicine. Our more than 4,000 employees worldwide are committed to ensuring everyone in the world with cancer has access to - and benefits from - more precise, personalized radiotherapy treatments. Headquartered in
https://news.cision.com/elekta/r/elekta-s-newest-radiotherapy-system--elekta-harmony--receives-ce-mark,c3232267
https://mb.cision.com/Main/35/3232267/1331315.pdf
https://news.cision.com/elekta/i/harmony-hires-0-approved,c2847219
https://news.cision.com/elekta/i/harmony-hires-2-approved,c2847220
(c) 2020 Cision. All rights reserved., source